Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aren van Waarde

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Molecular Pharmaceutics|September 27, 2012
Induction of β-glucuronidase release by cytostatic agents in small tumorsInês F Antunes, Hidde J Haisma, Philip H Elsinga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapyAnne Rixt Buursma, Antoine M J Beerens, Erik F J de Vries, et al.
Journal of Medicinal Chemistry|October 4, 2014
Synthesis and preclinical evaluation of 2-(2-furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C]Preladenant) as a PET tracer for the imaging of cerebral adenosine A2A receptorsXiaoyun Zhou, Shivashankar Khanapur, Anja P Huizing, et al.
Molecular Imaging and Biology|October 3, 2014
Altered sigma-1 receptor expression in two animal models of cognitive impairmentNisha K Ramakrishnan, Krisztina Marosi, Csaba J Nyakas, et al.
Psychopharmacology|March 19, 2014
Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPETNisha K Ramakrishnan, Anniek K D Visser, Marianne Schepers, et al.
Neuropharmacology|February 7, 2024
Effects of the adenosine A<sub>2A</sub> receptor antagonist KW6002 on the dopaminergic system, motor performance, and neuroinflammation in a rat model of Parkinson's diseaseKavya Prasad, Erik F J de Vries, Esther van der Meiden, et al.
Nuclear Medicine and Biology|March 27, 2012
In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent modelInês F Antunes, Hidde J Haisma, Philip H Elsinga, et al.
Pharmaceuticals (Basel, Switzerland)|October 18, 2017
Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET ImagingRenske M Raaphorst, Heli Savolainen, Mariangela Cantore, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent modelAren van Waarde, David C P Cobben, Albert J H Suurmeijer, et al.
Journal of Medicinal Chemistry|July 26, 2014
Development of [18F]-labeled pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) analogs for the imaging of cerebral adenosine A2A receptors with positron emission tomographyShivashankar Khanapur, Soumen Paul, Anup Shah, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Molecular Pharmaceutics|September 27, 2012
Induction of β-glucuronidase release by cytostatic agents in small tumorsInês F Antunes, Hidde J Haisma, Philip H Elsinga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapyAnne Rixt Buursma, Antoine M J Beerens, Erik F J de Vries, et al.
Journal of Medicinal Chemistry|October 4, 2014
Synthesis and preclinical evaluation of 2-(2-furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C]Preladenant) as a PET tracer for the imaging of cerebral adenosine A2A receptorsXiaoyun Zhou, Shivashankar Khanapur, Anja P Huizing, et al.
Molecular Imaging and Biology|October 3, 2014
Altered sigma-1 receptor expression in two animal models of cognitive impairmentNisha K Ramakrishnan, Krisztina Marosi, Csaba J Nyakas, et al.
Psychopharmacology|March 19, 2014
Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPETNisha K Ramakrishnan, Anniek K D Visser, Marianne Schepers, et al.
Neuropharmacology|February 7, 2024
Effects of the adenosine A<sub>2A</sub> receptor antagonist KW6002 on the dopaminergic system, motor performance, and neuroinflammation in a rat model of Parkinson's diseaseKavya Prasad, Erik F J de Vries, Esther van der Meiden, et al.
Nuclear Medicine and Biology|March 27, 2012
In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent modelInês F Antunes, Hidde J Haisma, Philip H Elsinga, et al.
Pharmaceuticals (Basel, Switzerland)|October 18, 2017
Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET ImagingRenske M Raaphorst, Heli Savolainen, Mariangela Cantore, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent modelAren van Waarde, David C P Cobben, Albert J H Suurmeijer, et al.
Journal of Medicinal Chemistry|July 26, 2014
Development of [18F]-labeled pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) analogs for the imaging of cerebral adenosine A2A receptors with positron emission tomographyShivashankar Khanapur, Soumen Paul, Anup Shah, et al.
Pageof 11